Abramson Cancer Center at Penn Medicine — Philadelphia, Pennsylvania

Abramson Cancer Center at Penn Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at Penn Medicine has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Endometrial Cancer, Near Infrared Fluorescence Imaging, CYTALUX (Pafolacianine) Injection.

Sponsors: Abramson Cancer Center at Penn Medicine.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at Penn Medicine?

Abramson Cancer Center at Penn Medicine has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at Penn Medicine conducted?

Abramson Cancer Center at Penn Medicine has 2 clinical trials on record, with 2 currently active. Their work covers Endometrial Cancer, Near Infrared Fluorescence Imaging, CYTALUX (Pafolacianine) Injection.

Is Abramson Cancer Center at Penn Medicine accredited by Crixeo Health?

Abramson Cancer Center at Penn Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center at Penn Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.